Mulai
ReutersReuters

Cybin Announces Additional U.S. Patent Supporting Its CYB003 Breakthrough Therapy Program In Phase 3 Development For Major Depressive Disorder

RefinitivWaktu baca kurang dari 1 menit
CYBN

Cybin Inc CYBN:

  • CYBIN ANNOUNCES ADDITIONAL U.S. PATENT SUPPORTING ITS CYB003 BREAKTHROUGH THERAPY PROGRAM IN PHASE 3 DEVELOPMENT FOR MAJOR DEPRESSIVE DISORDER

ReutersSaham ASSaham Kanada
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Masuk atau buat akun gratis selamanya untuk membaca berita ini

Berita lainnya dari Reuters